Iadademstat

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameIadademstat
Drug Alias NameRG-6016ORY-1001RO-7051790
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsPrimary MyelofibrosisMyeloproliferative DisordersMyelodysplastic Syndromes +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesDenmark +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOryzon Genomics Sa
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityOhsu Knight Cancer InstituteF. Hoffmann-La Roche Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisMyeloproliferative DisordersMyelodysplastic Syndromes +[9] 
Inactive IndicationsCarcinoma, Neuroendocrine

Other Information

ATC CodeN/A
Related LinksN/A